Amander T. Clark

Amander T. Clark

Auto-generated profile, based on publicly available information

Amander T. Clark

Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA 90095, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Cell
Verified
Journal Article
Closed access
SGSofia Gkountela
Sofia Gkountela
KZKelvin X. Zhang
Kelvin X. Zhang
TSTiasha A. Shafiq
Tiasha A. Shafiq
WLWen-Wei Liao
Wen-Wei Liao
JHJoseph Hargan-Calvopiña
Joseph Hargan-Calvopiña
ACAmander T. Clark
Amander T. Clark

1 March 2016 in Cell Stem Cell
Verified
Journal Article
Closed access
WPWilliam A. Pastor
William A. Pastor
DCDi Chen
Di Chen
WLWanlu Liu
Wanlu Liu
RKRachel Kim
Rachel Kim
ASAnna Sahakyan
Anna Sahakyan
ACAmander T. Clark
Amander T. Clark

29 December 2010 in Stem Cells
Verified
Journal Article
Open access
PDF file
SMSudip Mandal
Sudip Mandal
ALAnne G. Lindgren
Anne G. Lindgren
ASAnand S. Srivastava
Anand S. Srivastava
ACAmander T. Clark
Amander T. Clark
UBUtpal Banerjee
Utpal Banerjee
Pluripotent stem cells hold significant promise in regenerative medicine due to their unlimited capacity for self-renewal and potential to differentiate into any cell type of the body. In this study, we demonstrate that proper mitochondrial function is essential for proliferation of undifferentiated ESCs. Attenuating mitochondrial function under self-renewing conditions makes these cells more glycolytic-dependent, and it is associated with an increase in the mRNA reserves of Nanog, Oct4, and Sox2. In contrast, attenuating mitochondrial function during the first 7 days of differentiation results in normal repression of Oct4, Nanog, and Sox2. However, differentiation potential is compromised as revealed by abnormal transcription of multiple Hox genes. Furthermore, under differentiating conditions in which mitochondrial function is attenuated, tumorigenic cells continue to persist. Our results, therefore establish the importance of normal mitochondrial function in ESC proliferation, regulating differentiation, and preventing the emergence of tumorigenic cells during the process of differentiation.

15 January 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
JGJingtao Guo
Jingtao Guo
ESEnrique Sosa
Enrique Sosa
TCTsotne Chitiashvili
Tsotne Chitiashvili
XNXichen Nie
Xichen Nie
ERErnesto Javier Rojas
Ernesto Javier Rojas
BCBradley R. Cairns
Bradley R. Cairns

22 January 2009 in Stem Cells
Verified
Journal Article
Open access
PDF file
TPTae Sub Park
Tae Sub Park
ZGZoran Galic
Zoran Galic
ACAnne E. Conway
Anne E. Conway
ALAnne Lindgren
Anne Lindgren
BHBenjamin J. van Handel
Benjamin J. van Handel
ACAmander T. Clark
Amander T. Clark
The derivation of germ cells from human embryonic stem cells (hESCs) or human induced pluripotent stem (hIPS) cells represents a desirable experimental model and potential strategy for treating infertility. In the current study, we developed a triple biomarker assay for identifying and isolating human primordial germ cells (PGCs) by first evaluating human PGC formation during the first trimester in vivo. Next, we applied this technology to characterizing in vitro derived PGCs (iPGCs) from pluripotent cells. Our results show that codifferentiation of hESCs on human fetal gonadal stromal cells significantly improves the efficiency of generating iPGCs. Furthermore, the efficiency was comparable between various pluripotent cell lines regardless of origin from the inner cell mass of human blastocysts (hESCs), or reprogramming of human skin fibroblasts (hIPS). To better characterize the iPGCs, we performed Real-time polymerase chain reaction, microarray, and bisulfite sequencing. Our results show that iPGCs at day 7 of differentiation are transcriptionally distinct from the somatic cells, expressing genes associated with pluripotency and germ cell development while repressing genes associated with somatic differentiation (specifically multiple HOX genes). Using bisulfite sequencing, we show that iPGCs initiate imprint erasure from differentially methylated imprinted regions by day 7 of differentiation. However, iPGCs derived from hIPS cells do not initiate imprint erasure as efficiently. In conclusion, our results indicate that triple positive iPGCs derived from pluripotent cells differentiated on hFGS cells correspond to committed first trimester germ cells (before 9 weeks) that have initiated the process of imprint erasure. Disclosure of potential conflicts of interest is found at the end of this article.

1 December 2019 in Cell Reports
Verified
Journal Article
Open access
DCDi Chen
Di Chen
NSNa Sun
Na Sun
LHLei Hou
Lei Hou
RKRachel Kim
Rachel Kim
JFJared Faith
Jared Faith
ACAmander Clark
Amander Clark
In vitro gametogenesis is the process of making germline cells from human pluripotent stem cells. The foundation of this model is the quality of the first progenitors called primordial germ cells (PGCs), which in vivo are specified during the peri-implantation window of human development. Here, we show that human PGC (hPGC) specification begins at day 12 post-fertilization. Using single-cell RNA sequencing of hPGC-like cells (hPGCLCs) differentiated from pluripotent stem cells, we discovered that hPGCLC specification involves resetting pluripotency toward a transitional state with shared characteristics between naive and primed pluripotency, followed by differentiation into lineage-primed TFAP2A+ progenitors. Applying the germline trajectory to TFAP2C mutants reveals that TFAP2C functions in the TFAP2A+ progenitors upstream of PRDM1 to regulate the expression of SOX17. This serves to protect hPGCLCs from crossing the Weismann's barrier to adopt somatic cell fates and, therefore, is an essential mechanism for successfully initiating in vitro gametogenesis.